NCT03318172 is a NA clinical trial of Spinal Cord Stimulator in Pain, Intractable, sponsored by Seoul National University.

Who is sponsoring NCT03318172?

NCT03318172 is sponsored by Seoul National University.

What drugs are being tested in NCT03318172?

Interventions in NCT03318172: Spinal Cord Stimulator.

What condition does NCT03318172 study?

NCT03318172 studies Pain, Intractable.

Is NCT03318172 still recruiting?

NCT03318172 is currently terminated. Last updated 8 November 2022.

Last reviewed 2022-11-08 · How we verify

NCT03318172

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High-Density Spinal Cord Stimulation for the Treatment of Chronic Intractable Pain Patients

Terminated NA Last updated 8 November 2022

What this trial tests

NA trial testing Spinal Cord Stimulator in Pain, Intractable in 25 participants. Terminated before completion.

Timeline

14 July 2017

Primary endpoint
22 March 2018

12 April 2018

Quick facts

Lead sponsor	Seoul National University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	25
Start date	14 July 2017
Primary completion	22 March 2018
Estimated completion	12 April 2018
Sites	1 location across South Korea

Drugs / interventions tested

Spinal Cord Stimulator

Conditions studied

Pain, Intractable — all drugs for Pain, Intractable →

Sponsor

Seoul National University

Who can join

18 and older, any sex, with Pain, Intractable. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore which mode is effective in the management of intractable chronic pain, the high-density stimulation or the conventional stimulation, in patients who undergo SCS implantation after successful pre-implantation SCS trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Spinal Cord Stimulator

Trials testing the same drug.

NCT07139496 — Combined Injury-site & Lumbosacral Epidural Spinal Cord Stimulation · NA · recruiting
NCT05811143 — Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis. · completed
NCT06499220 — Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT) · NA · completed
NCT04159753 — Patient Experience Comparing Tonic Vs. Burst Spinal Cord Stimulation For Chronic Pain · NA · terminated
NCT03764514 — Spinal Cord Stimulation in Chemotherapy Induced Neuropathy · completed

Other recruiting trials for Pain, Intractable

Currently open trials in the same condition.

NCT07095036 — Sensory Spinal Cord Stimulation · NA · recruiting
NCT06596681 — A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain · EARLY_PHASE1 · recruiting
NCT05398003 — Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M) · NA · recruiting
NCT05761392 — APP-based Precise Management System of Chronic Intractable Pain · NA · recruiting
NCT04727216 — Intermittent vs. Continuous Dorsal Root Ganglion Stimulation · NA · active not recruiting

Other Seoul National University trials

Trials by the same sponsor.

NCT07385534 — Effects of Lower Body EMS Training in Postmenopausal Women · NA · recruiting
NCT06751108 — Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients · active not recruiting
NCT06703697 — Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe) · NA · recruiting
NCT06130514 — The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block · NA · not yet recruiting
NCT06470581 — Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03318172 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University
Last refreshed: 8 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03318172.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing